RNTX · Rein Therapeutics, Inc. · Documents
Market Cap
$64.56M
Shares
86.27M
Volume · Oct 5
336.14K
Avg daily vol (3M)
425.02K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-04 | — | |
| 8-K | 2026-08-27 | 2026-08-21 | |
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 8-K | 2026-07-21 | 2026-07-20 | |
| DEF 14A | 2026-06-08 | 2026-07-20 | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 8-K | 2026-05-04 | 2026-04-30 | |
| 10-K/A | 2026-04-27 | 2025-12-31 | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-03-02 | 2026-02-24 | |
| 8-K | 2026-02-19 | 2026-02-16 | |
| 8-K | 2026-01-16 | 2026-01-15 | |
| 8-K | 2025-12-11 | — | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-10-24 | 2025-10-23 | |
| 8-K | 2025-10-09 | — | |
| 8-K | 2025-09-22 | 2025-09-16 | |
| 8-K | 2025-09-09 | 2025-09-08 | |
| 8-K | 2025-08-19 | — | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 8-K | 2025-07-30 | 2025-07-29 | |
| 8-K | 2025-07-23 | — | |
| 8-K | 2025-07-11 | 2025-07-08 | |
| 8-K | 2025-06-24 | — | |
| 8-K | 2025-06-12 | 2025-06-10 | |
| 8-K | 2025-05-15 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| DEF 14A | 2025-05-12 | 2025-06-24 | |
| 10-K/A | 2025-04-30 | 2024-12-31 | |
| 8-K | 2025-04-22 | 2025-04-21 | |
| 8-K | 2025-04-17 | 2025-04-16 | |
| 10-K | 2025-04-07 | 2024-12-31 | |
| 8-K | 2025-01-10 | — | |
| 8-K | 2024-11-14 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-08-21 | 2024-08-20 | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-14 | — | |
| 8-K | 2024-07-26 | — | |
| DEF 14A | 2024-07-09 | 2024-08-20 | |
| 8-K | 2024-06-05 | — | |
| 8-K | 2024-05-16 | 2024-05-15 | |
| 8-K | 2024-05-15 | — | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 8-K | 2024-05-01 | — | |
| 8-K | 2024-05-01 | — | |
| 10-K/A | 2024-04-29 | 2023-12-31 | |
| 10-K | 2024-04-15 | 2023-12-31 | |
| 8-K | 2024-04-15 | — |
Showing 1–50 of 109 filings